- Baker Tilly Capital, LLC's Life sciences M&A newsletter provides an overview of the current industry's marketplace, highlighting key trends impacting performance and U.S. M&A activity.
- Baker Tilly’s international tax professionals discuss the role of IP migration for life sciences companies.
- Former CFO of Vascular Solutions (sold to Teleflex in 2016), describes his experience and the benefits of working with the Baker Tilly life sciences team.
- This webinar for manufacturers features an interactive panel discussion on what it takes to manage cybersecurity risk without full-time cybersecurity expertise on staff.
- The Tax Cuts and Jobs Act’s international tax provisions change the way U.S. multinationals are taxed and will conduct business abroad as well as how foreign companies will handle U.S. business.